Financhill
Back

Relmada Therapeutics Vs. Lifecore Biomedical Industry Stock Comparison

Sell
28

RLMD
Relmada Therapeutics

Last Price:
3.48
Seasonality Move:
-15.59%
Sell
35

LFCR
Lifecore Biomedical

Last Price:
5.78
Seasonality Move:
3.46%
Sell
28
Relmada Therapeutics (RLMD) is a Sell

Is Relmada Therapeutics a Buy, Sell or Hold?

  • The current Relmada Therapeutics [RLMD] share price is $3.49. The Score for RLMD is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • RLMD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
Lifecore Biomedical (LFCR) is a Sell

Is Lifecore Biomedical a Buy, Sell or Hold?

  • The current Lifecore Biomedical [LFCR] share price is $5.77. The Score for LFCR is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • LFCR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RLMD Stock Price Chart

What is Relmada Therapeutics's stock price today?

  • The Relmada Therapeutics share price today is $3.49
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RLMD is experiencing slight selling pressure.

LFCR Stock Price Chart

What is Lifecore Biomedical's stock price today?

  • The Lifecore Biomedical share price today is $5.77
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LFCR is experiencing selling pressure, which indicates risk of future bearish movement.

RLMD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.26 Sell
Relative Strength Index (14 RSI): 35.31 Sell
Chaikin Money Flow: -14510 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.52 - 4.24) Sell
Bollinger Bands (100): (3.57 - 5.47) Sell

LFCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.09 Sell
Relative Strength Index (14 RSI): 37.26 Sell
Chaikin Money Flow: -183991 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (6.14 - 6.64) Sell
Bollinger Bands (100): (5.93 - 7.69) Sell

RLMD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.64 Sell
20-day SMA: 3.72 Sell
50-day SMA: 4.47 Sell
200-day SMA: 3.75 Sell
8-day EMA: 3.6 Sell
20-day EMA: 3.81 Sell
50-day EMA: 4.21 Sell
200-day EMA: 4.37 Sell

LFCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.3 Sell
20-day SMA: 6.4 Sell
50-day SMA: 6.36 Sell
200-day SMA: 7.26 Sell
8-day EMA: 6.16 Sell
20-day EMA: 6.3 Sell
50-day EMA: 6.48 Sell
200-day EMA: 7.01 Sell

Relmada Therapeutics Earnings Growth & RLMD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.22 per share, and an increase next year of $0.26 per share.

Lifecore Biomedical Earnings Growth & LFCR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.18 per share, and an increase next year of $0.36 per share.

Relmada Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Lifecore Biomedical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):